LULU vs STRO · P/E 17, rev $11.10B vs rev $24.4M
Lululemon Athletica Inc. (LULU) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. Revenue was up 4.9% from 2025-02-02 to 2026-02-01. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Latest reported STRO revenue for 2026-06-30 was $24.4M. Net income was -$77.0M. Revenue was up 67.7% from 2026-03-31 to 2026-06-30. STRO currently screens at market cap $470.8M.
LULU currently screens at market cap $29.68B and trailing P/E 16.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LULU and STRO stock pages for the full models.
Not investment advice.